-
Je něco špatně v tomto záznamu ?
Thermodynamics of the interaction between oxytocin and its myometrial receptor in sheep: a stepwise binding mechanism
V. Pliska, G. Folkers, V. Spiwok,
Jazyk angličtina Země Anglie, Velká Británie
Typ dokumentu časopisecké články, práce podpořená grantem
- MeSH
- arginin vasopresin metabolismus MeSH
- buněčná membrána metabolismus MeSH
- myometrium metabolismus MeSH
- ovce MeSH
- oxytocin metabolismus MeSH
- receptory oxytocinu metabolismus MeSH
- teplota MeSH
- termodynamika MeSH
- vasotocin analogy a deriváty metabolismus MeSH
- vazebná místa MeSH
- zvířata MeSH
- Check Tag
- ženské pohlaví MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
Entropy (ΔS), enthalpy (ΔH) and heat capacity (ΔCp) changes attending the oxytocin interaction with its two binding sites on myometrial cell membranes in sheep were derived from the temperature dependence of Kd values. The high affinity oxytocin site (Kd on the order of 10(-9)mol l(-1), 25 °C), ascribed to the oxytocin receptor (OXTR), is entropy-driven in the temperature range 0-37 °C. Enthalpy component prevails as a driving force in the binding to the low affinity site (Kd ≈ 10(-7)) within the higher temperature range. ΔCp values in both cases do not differ significantly from zero but become highly relevant in the presence of a GTP analog (10(-4)M GTP-γS). Under these conditions, ΔCp in the low site interaction becomes negative and ΔS is shifted toward negative values (enthalpy drift); ΔCp of the high affinity site rises to a high positive value and the interaction is even more strongly entropy driven. Atosiban, a competitive antagonist of oxytocin at OXTR displays a single significant binding site on myometrial cells (Kd about 10(-7)mol l(-1)). Thermodynamic profiles of atosiban and the low affinity oxytocin site show conspicuous similarities, indicating that the inhibitor is bound to the low affinity site, and not, with a lower affinity, to the putative receptor protein. It is suggested that the interaction of oxytocin with its responding system on myometrial membranes follows in two distinct steps that are likely to be associated with several independent binding domains in the GPCR receptor.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc15007993
- 003
- CZ-PrNML
- 005
- 20150312130139.0
- 007
- ta
- 008
- 150306s2014 enk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.bcp.2014.06.025 $2 doi
- 035 __
- $a (PubMed)25010721
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a enk
- 100 1_
- $a Pliska, Vladimir $u Collegium Helveticum, Swiss Federal Institute of Technology (ETH-Zürich) and University of Zurich, Schmelzbergstrasse 25, CH-8092 Zürich, Switzerland; Institute of Pharmaceutical Sciences, Swiss Federal Institute of Technology (ETH-Zürich), Campus Hönggerberg, CH-8093 Zürich, Switzerland. Electronic address: pliska@collegium.ethz.ch.
- 245 10
- $a Thermodynamics of the interaction between oxytocin and its myometrial receptor in sheep: a stepwise binding mechanism / $c V. Pliska, G. Folkers, V. Spiwok,
- 520 9_
- $a Entropy (ΔS), enthalpy (ΔH) and heat capacity (ΔCp) changes attending the oxytocin interaction with its two binding sites on myometrial cell membranes in sheep were derived from the temperature dependence of Kd values. The high affinity oxytocin site (Kd on the order of 10(-9)mol l(-1), 25 °C), ascribed to the oxytocin receptor (OXTR), is entropy-driven in the temperature range 0-37 °C. Enthalpy component prevails as a driving force in the binding to the low affinity site (Kd ≈ 10(-7)) within the higher temperature range. ΔCp values in both cases do not differ significantly from zero but become highly relevant in the presence of a GTP analog (10(-4)M GTP-γS). Under these conditions, ΔCp in the low site interaction becomes negative and ΔS is shifted toward negative values (enthalpy drift); ΔCp of the high affinity site rises to a high positive value and the interaction is even more strongly entropy driven. Atosiban, a competitive antagonist of oxytocin at OXTR displays a single significant binding site on myometrial cells (Kd about 10(-7)mol l(-1)). Thermodynamic profiles of atosiban and the low affinity oxytocin site show conspicuous similarities, indicating that the inhibitor is bound to the low affinity site, and not, with a lower affinity, to the putative receptor protein. It is suggested that the interaction of oxytocin with its responding system on myometrial membranes follows in two distinct steps that are likely to be associated with several independent binding domains in the GPCR receptor.
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a arginin vasopresin $x metabolismus $7 D001127
- 650 _2
- $a vazebná místa $7 D001665
- 650 _2
- $a buněčná membrána $x metabolismus $7 D002462
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a myometrium $x metabolismus $7 D009215
- 650 _2
- $a oxytocin $x metabolismus $7 D010121
- 650 _2
- $a receptory oxytocinu $x metabolismus $7 D018045
- 650 _2
- $a ovce $7 D012756
- 650 _2
- $a teplota $7 D013696
- 650 _2
- $a termodynamika $7 D013816
- 650 _2
- $a vasotocin $x analogy a deriváty $x metabolismus $7 D014668
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Folkers, Gerd $u Collegium Helveticum, Swiss Federal Institute of Technology (ETH-Zürich) and University of Zurich, Schmelzbergstrasse 25, CH-8092 Zürich, Switzerland; Institute of Pharmaceutical Sciences, Swiss Federal Institute of Technology (ETH-Zürich), Campus Hönggerberg, CH-8093 Zürich, Switzerland.
- 700 1_
- $a Spiwok, Vojtěch $u Department of Biochemistry and Microbiology, Institute of Chemical Technology (VŠCHT-Prague), Technická 5, CZ-166 28 Praha 6, Czech Republic.
- 773 0_
- $w MED00000704 $t Biochemical pharmacology $x 1873-2968 $g Roč. 91, č. 1 (2014), s. 119-27
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/25010721 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20150306 $b ABA008
- 991 __
- $a 20150312130418 $b ABA008
- 999 __
- $a ok $b bmc $g 1065266 $s 890793
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2014 $b 91 $c 1 $d 119-27 $i 1873-2968 $m Biochemical pharmacology $n Biochem Pharmacol $x MED00000704
- LZP __
- $a Pubmed-20150306